Catatonia during pregnancy and the postpartum period.

Benzodiazepines Catatonia Electroconvulsive therapy Perinatal Postpartum Pregnancy

Journal

Schizophrenia research
ISSN: 1573-2509
Titre abrégé: Schizophr Res
Pays: Netherlands
ID NLM: 8804207

Informations de publication

Date de publication:
03 Sep 2022
Historique:
received: 06 06 2022
revised: 09 08 2022
accepted: 10 08 2022
entrez: 5 9 2022
pubmed: 6 9 2022
medline: 6 9 2022
Statut: aheadofprint

Résumé

While the psychopathology of mental disorders during pregnancy and the postpartum period is a growing area of research, the prevalence and significance of catatonic symptoms has been relatively neglected. To address this gap in knowledge, a systematic review of articles on catatonia occurring during pregnancy and the postpartum period was conducted. PubMed, Excerpta Medica, (later EMBASE) databases were queried for articles published in English from their inception in 1966 and 1946, respectively to May 31. 2022 using the terms "catatonia", AND "perinatal", "puerperal", "postpartum", "antepartum" "lactation" "pregnancy" or "pregnancy-related", supplemented by a manual search of references. This review failed to identify any well-designed, prospective, or controlled studies addressing the subject of catatonia during pregnancy or the postpartum period; only one retrospective chart review, a single small case series, and twenty single case reports were found. The limited literature suggests that the clinical presentation and treatment response during pregnancy and after childbirth are similar to catatonia observed in other contexts. Catatonic signs and symptoms could affect physical and mental health, markedly compromising a mother's ability to take care of and bond with her infant. Further studies are needed to advance understanding of the role of catatonia in the pathogenesis, diagnosis and treatment of perinatal mental disorders.

Identifiants

pubmed: 36064493
pii: S0920-9964(22)00305-X
doi: 10.1016/j.schres.2022.08.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest Dr. Caroff received research grants for unrelated projects from Neurocrine Biosciences and Eagle Pharmaceuticals and served as consultant for Neurocrine Biosciences and Adamas Pharmaceuticals. The other authors have no declarations of interest to report.

Auteurs

Levente Csihi (L)

Department of Psychiatry and Psychiatric Rehabilitation, Jahn Ferenc South Pest Hospital, Budapest, Hungary.

Gabor S Ungvari (GS)

Division of Psychiatry, School of Medicine, University of Western Australia, Crawley, Australia; Section of Psychiatry, University of Notre Dame, Fremantle, Australia.

Stanley N Caroff (SN)

Corporal Michael J. Crescenz VA Medical Center, Philadelphia, USA; University of Pennsylvania Perelman School of Medicine, Philadelphia, USA.

Stephan C Mann (SC)

Central Montgomery Behavioral Health, Norristown, PA, USA.

Gábor Gazdag (G)

Department of Psychiatry and Psychiatric Rehabilitation, Jahn Ferenc South Pest Hospital, Budapest, Hungary; Department of Psychiatry and Psychotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary. Electronic address: gazdag@lamb.hu.

Classifications MeSH